Name | propan-2-yl (2R,3S)-4-cyclohexyl-2-hydroxy-3-[[(2R)-3-methylsulfanyl-2-[[(2S)-2-(morpholine-4-carbonylamino)-3-phenylpropanoyl]amino]propanoyl]amino]butanoate |
---|---|
Synonyms |
Terlakiren (USAN/INN)
N-(Morpholin-4-Ylcarbonyl)-L-Phenylalanyl-N-[(1r,2s)-1-(Cyclohexylmethyl)-2-Hydroxy-3-(1-Methylethoxy)-3-Oxopropyl]-S-Methyl-L-Cysteinamide 2ZS [R-(R*,S*)]-N-(4-morpholinylcarbonyl)-L-phenylalanyl-N-[1-(cyclohexylmethyl)-2-hydroxy-3-(1-methylethoxy)-3-oxopropyl]-(S)-methyl-L-cysteineamide MOR-PHE-CYM-NOR |
Description | Terlakiren (CP-80,794) is an orally active inhibitor of renin. Terlakiren inhibits the efficacy of human renin with an IC50 value of 0.7 nM. Terlakiren has potential applications in hypertension[1]. |
---|---|
Related Catalog | |
References |
Density | 1.205g/cm3 |
---|---|
Boiling Point | 908.3ºC at 760mmHg |
Molecular Formula | C31H48N4O7S |
Molecular Weight | 620.80 |
Flash Point | 503.1ºC |
Exact Mass | 620.32400 |
PSA | 171.60000 |
LogP | 3.36560 |
Vapour Pressure | 0mmHg at 25°C |
Index of Refraction | 1.554 |